Correlation Between Pliant Therapeutics and Dice Molecules

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Dice Molecules at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Dice Molecules into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Dice Molecules Holdings, you can compare the effects of market volatilities on Pliant Therapeutics and Dice Molecules and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Dice Molecules. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Dice Molecules.

Diversification Opportunities for Pliant Therapeutics and Dice Molecules

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pliant and Dice is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Dice Molecules Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dice Molecules Holdings and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Dice Molecules. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dice Molecules Holdings has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Dice Molecules go up and down completely randomly.

Pair Corralation between Pliant Therapeutics and Dice Molecules

If you would invest  4,697  in Dice Molecules Holdings on August 30, 2024 and sell it today you would earn a total of  0.00  from holding Dice Molecules Holdings or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.55%
ValuesDaily Returns

Pliant Therapeutics  vs.  Dice Molecules Holdings

 Performance 
       Timeline  
Pliant Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pliant Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Pliant Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Dice Molecules Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dice Molecules Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dice Molecules is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pliant Therapeutics and Dice Molecules Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pliant Therapeutics and Dice Molecules

The main advantage of trading using opposite Pliant Therapeutics and Dice Molecules positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Dice Molecules can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dice Molecules will offset losses from the drop in Dice Molecules' long position.
The idea behind Pliant Therapeutics and Dice Molecules Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.